OncoGenex Pharma (OGXI) Tops Q3 EPS by 14c

November 10, 2016 4:28 PM EST
Get Alerts OGXI Hot Sheet
Trade OGXI Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

OncoGenex Pharma (NASDAQ: OGXI) reported Q3 EPS of ($0.12), $0.14 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on OncoGenex Pharma (OGXI) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment